KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Castle Biosciences (CSTL) Shares Outstanding (2018 - 2023)

Historic Shares Outstanding for Castle Biosciences (CSTL) over the last 6 years, with Q2 2023 value amounting to $26.8 million.

  • Castle Biosciences' Shares Outstanding rose 187.02% to $26.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $26.8 million, marking a year-over-year increase of 187.02%. This contributed to the annual value of $26.6 million for FY2022, which is 463.05% up from last year.
  • Latest data reveals that Castle Biosciences reported Shares Outstanding of $26.8 million as of Q2 2023, which was up 187.02% from $26.7 million recorded in Q1 2023.
  • Castle Biosciences' Shares Outstanding's 5-year high stood at $26.8 million during Q2 2023, with a 5-year trough of $1.9 million in Q1 2019.
  • Its 5-year average for Shares Outstanding is $21.0 million, with a median of $25.1 million in 2021.
  • In the last 5 years, Castle Biosciences' Shares Outstanding soared by 79755.76% in 2020 and then soared by 171.99% in 2022.
  • Quarter analysis of 5 years shows Castle Biosciences' Shares Outstanding stood at $17.1 million in 2019, then skyrocketed by 44.84% to $24.8 million in 2020, then grew by 2.28% to $25.4 million in 2021, then rose by 4.63% to $26.6 million in 2022, then increased by 0.87% to $26.8 million in 2023.
  • Its Shares Outstanding stands at $26.8 million for Q2 2023, versus $26.7 million for Q1 2023 and $26.6 million for Q4 2022.